FTC targets spammers
This article was originally published in The Tan Sheet
Executive Summary
A U.S. district court in Illinois ordered a halt to spam e-mails and bogus claims for Kaycon's hoodia weight-loss supplements and human growth hormone anti-aging products after FTC filed a complaint against the firm. Kaycon falsely claimed its hoodia products would cause rapid and substantial weight loss, "including as much as 40 pounds in a month" and its HGH products would "turn back or reverse the aging process," among other claims, FTC states. The federal court ordered an ex parte temporary restraining order and asset freeze of the firm, and will decide after an Aug. 27 hearing whether to extend the asset freeze until the FTC's case is resolved. The FTC ultimately seeks to permanently bar the firm from further violations and it forfeit its "ill-gotten gains"...
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.